Press Release
AstraZeneca Rhythm Pharmaceuticals Acquisition to Expand Rare Disease Portfolio
AstraZeneca has reportedly made a non-binding offer worth approximately $10 billion to acquire Rhythm Pharmaceuticals, a US-based biotechnology company specialising ...
Integrating Cold Plunge Sessions Into Holistic Rehabilitation Programs for Athletes
All athletes have a well-developed sense for what it feels like to have given everything on the track, on the ...
Dental Implants Explained: What to Expect Before During and After Treatment
Missing teeth can do more than ruin a smile – they also hinder mastication, cause speech impediments, and permit adjacent ...
Key Features to Compare Before Choosing AI Medical Scribe Software
Choosing AI medical scribe software involves more than finding a tool that converts patient conversations into clinical notes. Medical practices ...
Boehringer Sino Biopharma Cancer Drug Deal Worth $7B To Cover Six Experimental Programmes
Boehringer Ingelheim has signed a cancer drug licensing agreement with China’s Sino Biopharmaceutical (SBP Group) that could be worth up ...
Optimizing the Financial Heartbeat: How Modern Revenue Cycle Management Transforms Healthcare Delivery
Healthcare organizations operate at a delicate and demanding intersection: delivering top-tier patient care while maintaining long-term financial sustainability. In an ...